Risk of cause-specific death in individuals with diabetes: A competing risks analysis

Diabetes Care

Volumn 39, Issue 11, 2016, Pages 1987-1995

  Baena Díez, Jose Miguel ^a,b,c   Peñafiel, Judit ^a   Subirana, Isaac ^a,c   Ramos, Rafel ^b,d   Elosua, Roberto ^a   Marín Ibañez, Alejandro ^e   Guembe, María Jesús ^f,g   Rigo, Fernando ^h   Tormo Díaz, María José ^b,i,j,k   Moreno Iribas, Conchi ^l,m,n   Cabré, Joan Josep ^b   Segura, Antonio ^o   García Lareo, Manel ^b   De La Cámara, Agustín Gómez ^c,p   Lapetra, José ^q,r   Quesada, Miquel ^b   Marrugat, Jaume ^a   Medrano, Maria José ^s   Berjón, Jesús ^f,n   Frontera, Guiem ^h   Gavrila, Diana ^c,t   Barricarte, Aurelio ^c,l,n   Basora, Josep ^b   García, Jose María ^o   Pavone, Natalia C ^b   Lora Pablos, David ^c,p   Mayoral, Eduardo ^q,u   Franch, Josep ^b,v   Mata, Manel ^b   Castell, Conxa ^w   Frances, Albert ^a   Grau, María ^a,x   more..

^a HOSPITAL DEL MAR   (Spain)

^b INSTITUT CATALÀ DE LA SALUT   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d UNIVERSITY OF GIRONA   (Spain)

^e San José Norte Health Centre   (Spain)

^f Vascular Risk in Navarra Research Group   (Spain)

^g Government of Navarra   (Spain)

^h Cardiovascular Group of Balearic Islands   (Spain)

ⁱ Clinical Nurse of Primary Health Care Murcian Health Service   (Spain)

^j UNIVERSITY OF MURCIA   (Spain)

^k Murcian Institute of Biomedical Research   (Spain)

^l INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^m Research Network for Health Services in Chronic Disease (REDISSEC)   (Spain)

ⁿ Recinto de Complejo Hospitalario de Navarra   (Spain)

^o Health Science Institute   (Spain)

^p HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^q Primary Care Center San Pablo ^*  (Spain)

^r Primary Care Center San José   (Spain)

^s INSTITUTO DE SALUD CARLOS III   (Spain)

^t Murcia Regional Government   (Spain)

^u Andalusia Health Service   (Spain)

^v INSTITUTO DE SALUD CARLOS III   (Spain)

^w AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^x UNIVERSITY OF BARCELONA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOMETABOLIC RISK; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; RISK ASSESSMENT; SELF REPORT; SEX DIFFERENCE; VITAL STATISTICS; CARDIOVASCULAR DISEASE; COMPLICATION; INSULIN DEPENDENT DIABETES MELLITUS; LIFE EXPECTANCY; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR;

GLUCOSE BLOOD LEVEL;

ADULT; AGED; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; RISK ASSESSMENT; RISK FACTORS;

EID: 84994300380     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc16-0614     Document Type: Article

References (40)

1. Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 2011;378: 169-181
2. International Diabetes Federation. IDF Diabetes Atlas. 6th ed. Available from http://www.idf .org/diabetesatlas. Accessed 21 January 2016
3. Soriguer F, Goday A, Bosch-Comas A, et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: The Di@bet.es Study. Diabetologia 2012;55:88-93
4. Grau M, Elosua R, Cabrera de León A, et al. [Cardiovascular risk factors in Spain in the first decade of the 21st Century, a pooled analysis with individual data from 11 population-based studies: The DARIOS study]. Rev Esp Cardiol 2011;64:295-304
5. Seshasai SR, Kaptoge S, Thompson A, et al.; Emerging Risk Factors Collaboration. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011;364:829-841
6. Sarwar N, Gao P, Seshasai SR, et al.; Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet 2010;375:2215-2222
7. Tancredi M, Rosengren A, Svensson AM, et al. Excess Mortality among Persons with Type 2 Diabetes. N Engl J Med 2015;373:1720-1732
8. Atchison EA, Gridley G, Carreon JD, Leitzmann MF, McGlynn KA. Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer 2011; 128:635-643
9. Wolbers M, Koller MT, Stel VS, et al. Competing risks analyses: objectives and approaches. Eur Heart J 2014;35:2936-2941
10. Pintilie M. [An introduction to competing risks analysis]. Rev Esp Cardiol 2011;64:599-605
11. Andersen PK, Geskus RB, de Witte T, Putter H. Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol 2012;41:861-870
12. Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data. Am J Epidemiol 2009;170:244-256
13. Latouche A, Allignol A, Beyersmann J, Labopin M, Fine JP. A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions. J Clin Epidemiol 2013;66:648-653
14. Marrugat J, Subirana I, Ramos R, et al.; FRESCO Investigators. Derivation and validation of a set of 10-year cardiovascular risk predictive functions in Spain: The FRESCO Study. Prev Med 2014;61:66-74
15. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583-612
16. Ahmad OE, Boschi-Pinto C, Lopez AD, et al. Age Standardization of Rates: A New WHO Sandard. GPE Discussion Paper Series: No. 31. Geneva, World Health Organization, 2000.
17. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496-509
18. Scrucca L, Santucci A, Aversa F. Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant 2007;40:381-387
19. Gregg EW, Li Y, Wang J, et al. Changes in diabetes-related complications in theUnited States, 1990-2010. N Engl J Med 2014;370:1514-1523
20. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339: 229-234
21. Cano JF, Baena-Diez JM, Franch J, et al.; REGICOR and GEDAPS Investigators. Long-term cardiovascular risk in type 2 diabetic compared with nondiabetic first acute myocardial infarction patients: A population-based cohort study in southern Europe. Diabetes Care 2010;33: 2004-2009
22. Bulugahapitiya U, Siyambalapitiya S, Sithole J, Idris I. Is diabetes a coronary risk equivalent? Systematic review and meta-analysis. Diabet Med 2009;26:142-148
23. Wang C, Wang X, Gong G, et al. Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta-analysis of cohort studies. Int J Cancer 2012;130:1639-1648
24. Jiang Y, Ben Q, Shen H, LuW, Zhang Y, Zhu J. Diabetes mellitus and incidence and mortality of colorectal cancer: A systematic review and meta-analysis of cohort studies. Eur J Epidemiol 2011;26:863-876
25. Colhoun H. Coronary heart disease in women: why the disproportionate risk? Curr Diab Rep 2006;6:22-28
26. Avogaro A, Giorda C, Maggini M, et al.; Diabetes and Informatics Study Group, Association of Clinical Diabetologists, Istituto Superiore di Sanita. Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location. Diabetes Care 2007;30: 1241-1247
27. Barone BB, Yeh HC, Snyder CF, et al. Longterm all-cause mortality in cancer patients with preexisting diabetes mellitus: A systematic review and meta-analysis. JAMA 2008;300:2754-2764
28. Verlato G, Zoppini G, Bonora E, Muggeo M. Mortality from site-specific malignancies in type 2 diabetic patients from Verona. Diabetes Care 2003;26:1047-1051
29. Hu G; DECODE Study Group. Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia 2003;46:608-617
30. Kahn R, Alperin P, Eddy D, et al. Age at initiation and frequency of screening to detect type 2 diabetes: A cost-effectiveness analysis. Lancet 2010;375:1365-1374
31. Sumamo E, Ha C, Korownyk C, et al. Lifestyle interventions for four conditions: type 2 diabetes, metabolic syndrome, breast cancer, and prostate cancer [Internet], 2011. Rockville, MD, Agency for Healthcare Research and Quality. Available from http://www.ncbi.nlm.nih.gov/books/NBK254022/. Accessed 21 January 2016
32. Hemmingsen B, Lund SS, Gluud C, et al. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Cochrane Database Syst Rev 2013;11:CD008143
33. Tricco AC, Ivers NM, Grimshaw JM, et al. Effectiveness of quality improvement strategies on the management of diabetes: A systematic review and meta-analysis. Lancet 2012;379: 2252-2261
34. Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in U.S. diabetes care, 1999-2010. N Engl J Med 2013;368:1613-1624
35. Agüero F, Dégano IR, Subirana I, et al. Impact of a partial smoke-free legislation on myocardial infarction incidence, mortality and case-fatality in a population-based registry: The REGICOR Study. PLoS One 2013;8:e53722
36. Dale AC, Vatten LJ, Nilsen TI, Midthjell K, Wiseth R. Secular decline in mortality from coronary heart disease in adults with diabetes mellitus: cohort study. BMJ 2008;337: a236
37. Gregg EW, Cheng YJ, Saydah S, et al. Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey. Diabetes Care 2012;35:1252-1257
38. Lind M, Garcia-Rodriguez LA, Booth GL, et al. Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: A population-based study. Diabetologia 2013;56:2601-2608
39. Vinagre I, Mata-CasesM, Hermosilla E, et al. Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain). Diabetes Care 2012; 35:774-779
40. Ruiz-Ramos M, Escolar-Pujolar A, Mayoral-Sánchez E, Corral-San Laureano F, Fernández-Fernández I. [Diabetes mellitus in Spain: death rates, prevalence, impact, costs and inequalities]. Gac Sanit 2006;20(Suppl. 1):15-24